design your own beats headphones online

 

CADRE is a non-profit organization committed to reducing the burden of diabetes by providing health care professionals with scientific information and educational initiatives designed to translate research into effective clinical practice. 

 

Diabetes Education from CADRE 
  • CADRE's Current Diabetes Practice - The current issue of the CADRE newsletter contains information on glucose monitoring for diabetes control, including articles offering different viewpoints on the use of A1C for diagnosis of diabetes.  You can also read archived issues. 
  • Cases in Success - Web-based, interactive case studies about various treatment strategies for type 2 diabetes.  Although accreditation for these case studies has expired, you can still obtain valuable information and complete the cases for your own non-accredited education. 
  • CADRE's I DO initiative to Impact Diabetes Outcomes is a multi-year curriculum covering the spectrum of diabetes management, including: 
       - Cardiovascular risk management
       - Diabetic kidney disease
       - Diabetic peripheral neuropathy
       - Hypoglycemia
       - Insulin therapy
       - New antidiabetic therapies
       - Special populations
       - Weight management
    Our goal for I DO is to provide healthcare practitioners with the tools to translate cutting-edge research into improved clinical management and improved outcomes for individual patients.  As I DO programs are developed, links will be posted on this page.  
       »II DO seek the most up-to-date information
         about diabetes treatment strategies

Funding for CADRE

CADRE's educational activities are funded from many sources, including Amylin Pharmaceuticals, Amylin-Lilly, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly & Company, GlaxoSmithKline, Johnson & Johnson, LifeScan, Merck & Co., Novartis, Novo Nordisk, Nutrition 21, Pfizer, and sanofi-aventis. 

 

Resources

 

 

 
 
forgot password?

MONTHLY MESSAGE:
CADRE's Cases in Success